Screening for early stage cancer has gained a promising entrant with Thrive Earlier Detection Corp., which has raised a $110 million series A round to back its ongoing pan-cancer detection research. The Cambridge, Mass.-based startup was spun out of Johns Hopkins University, where the science backing it was already relatively far along. Read More
